Related Experiment Video
Updated: Dec 30, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Patients' characteristics and their adherence to insulin therapy
Yunti Fitriani1, Liza Pristianty2, Andi Hermansyah2
1Province Level Health Office East Java, 60231 Surabaya, Indonesia.
Abstract:
Background The prevalence of type 2 diabetes mellitus (DMT2) in Indonesia increased significantly from 6.9% (2013) to 8.5% (2018), putting Indonesia in top six countries in the world with maximum DMT2 patients. Patients with uncontrolled DMT2 are at risk for complications. As such, insulin is often administered to keep the levels under control. Unfortunately, poor adherence to insulin therapy is common, reflecting some factors that may affect the therapy. The aim of this study was to identify and analyze the characteristics of patients contributing to adherence to insulin therapy among DMT2 outpatients using the Health Belief Model (HBM) approach. Methods A cross-sectional survey was conducted on a sample of 84 DMT2 outpatients in a private hospital in Surabaya between April and May 2019. Respondents were selected using the accidental sampling technique. Data were analyzed using descriptive analysis and chi-square. Results The level of respondents' adherence was high (73.8%). There was no significant relationship between sex, age, level of education, occupation, and duration of use and patient adherence. Using the HBM approach, this study showed a significant relationship between the five components of HBM (perceived susceptibility, perceived severity, perceived benefit, perceived barrier and perceived self-efficacy) and patient adherence. Conclusions Patient adherence was influenced primarily by patient belief to the therapy of insulin. The characteristics of patients had no effect on adherence, yet further research is recommended to examine such adherence to a different population.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational

